OCA real world experience
Since OCA (Ocaliva) was approved in the US in 2016 and Canada in 2017, there have been several studies to assess its effectiveness in PBC patients around the world. Here are some links to those studies.
Hirschfield, Hansen: OCA improves AST-to-platelet ratio index and GLOBE score in PBC
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724188/
Italian real-world experience with OCA
https://pubmed.ncbi.nlm.nih.gov/33681748/
Iberian real-world experience with OCA
https://pubmed.ncbi.nlm.nih.gov/33314220/
Canadian (CaNAL) real-world experience with OCA (July 2020)